[HTML][HTML] ω-6 polyunsaturated fatty acids and cardiometabolic health: current evidence, controversies, and research gaps

KC Maki, F Eren, ME Cassens, MR Dicklin… - Advances in …, 2018 - Elsevier
Abstract The 2015 Dietary Guidelines for Americans recommend limiting the intake of
saturated fatty acids (SFAs) to< 10% of energy/d and replacing dietary SFAs with …

[HTML][HTML] Emerging nutrition science on fatty acids and cardiovascular disease: nutritionists' perspectives

PM Kris-Etherton, JA Fleming - Advances in Nutrition, 2015 - Elsevier
Recent dietary guidance for heart health recommends a reduction (by∼ 50%) in saturated
fatty acid (SFA) intake to reduce LDL cholesterol and to decrease risk of cardiovascular …

Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events

D Mozaffarian, JHY Wu - Journal of the American College of Cardiology, 2011 - jacc.org
We reviewed available evidence for cardiovascular effects of n-3 polyunsaturated fatty acid
(PUFA) consumption, focusing on long chain (seafood) n-3 PUFA, including their principal …

Do omega-3 polyunsaturated fatty acids prevent cardiovascular disease? A review of the randomized clinical trials

LM Kimmig, DG Karalis - Lipid Insights, 2013 - journals.sagepub.com
Fish oil is rich in the omega-3 polyunsaturated fatty acids (PUFAs) eicosapentaenoic acid
(EPA) and docosahexaenoic acid (DHA). Numerous epidemiological studies and several …

Omega-3 fatty acid supplementation and cardiovascular disease risk: glass half full or time to nail the coffin shut?

KC Maki, MR Dicklin - Nutrients, 2018 - mdpi.com
There has been a great deal of controversy in recent years about the potential role of dietary
supplementation with long-chain omega-3 polyunsaturated fatty acids (n-3 PUFA) in the …

[HTML][HTML] The potential cardiometabolic effects of long-chain ω-3 polyunsaturated fatty acids: recent updates and controversies

JH Bae, H Lim, S Lim - Advances in Nutrition, 2023 - Elsevier
Various health-related effects of long-chain (LC) ω-3 PUFAs, EPA, and DHA have been
suggested. LC ω-3 PUFAs reduce TG concentrations and have anti-inflammatory …

Dietary and pharmacological fatty acids and cardiovascular health

H Wu, L Xu, CM Ballantyne - The Journal of Clinical …, 2020 - academic.oup.com
Context The effects of dietary intake of different fatty acids and pharmacological use of fatty
acids, specifically long-chain n-3 polyunsaturated fatty acids (LC n-3 PUFAs), on …

Fatty acids in cardiovascular health and disease: a comprehensive update

SJ Baum, PM Kris-Etherton, WC Willett… - Journal of clinical …, 2012 - Elsevier
Research dating back to the 1950s reported an association between the consumption of
saturated fatty acids (SFAs) and risk of coronary heart disease. Recent epidemiological …

Omega-3 fatty acids and cardiovascular disease: are there benefits?

KJ Bowen, WS Harris, PM Kris-Etherton - Current treatment options in …, 2016 - Springer
Opinion statement Early secondary prevention trials of fish and omega-3 polyunsaturated
fatty acid (PUFA) capsules reported beneficial effects on cardiovascular disease (CVD) …

Dietary n-6 polyunsaturated fatty acids and cardiovascular disease: Epidemiologic evidence

DD Wang - Prostaglandins, Leukotrienes and Essential Fatty Acids, 2018 - Elsevier
Epidemiologists have been studying the effect of n-6 polyunsaturated fatty acids (PUFAs)
intake on the risk of cardiovascular disease (CVD) for many decades. Abundant evidence …